Why Quest Diagnostics Stock Climbed This Past Week
Demand for medical testing services is rising.
Overview
Shares of Quest Diagnostics (NYSE: DGX) rose more than 8% last week after the medical testing leader boosted its full-year sales and profit forecast.
Image source: Getty Images.
Quest's revenue jumped 10% year over year to $3 billion in the second quarter.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.